MACI LINDQUIST: Open Payments
NPI 1831813526 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 40 payments from 12 companies in 2025. Trend: 2023 $873 · 2024 $484 · 2025 $1,233
Food & beverage: $1,215Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $429 |
| GENZYME CORPORATION | 4 | $269 |
| GlaxoSmithKline, LLC. | 10 | $188 |
| Lilly USA, LLC | 2 | $128 |
| Insmed, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Viatris Specialty LLC | 2 | $33 |
| Amgen Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $22 |
Products named: DUPIXENT, BREZTRI, ZEPBOUND, NUCALA, AIRSUPRA, TRELEGY ELLIPTA, FASENRA, TEZSPIRE.
Industry payments across SC — which companies pay providers there.
